Canada markets closed
  • S&P/TSX

    20,928.10
    +108.16 (+0.52%)
     
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • DOW

    35,294.76
    +382.20 (+1.09%)
     
  • CAD/USD

    0.8087
    +0.0001 (+0.01%)
     
  • CRUDE OIL

    82.66
    +1.35 (+1.66%)
     
  • BTC-CAD

    76,239.56
    +2,817.85 (+3.84%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • GOLD FUTURES

    1,768.10
    -29.80 (-1.66%)
     
  • RUSSELL 2000

    2,265.65
    -8.52 (-0.37%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • NASDAQ

    14,897.34
    +73.91 (+0.50%)
     
  • VOLATILITY

    16.30
    -0.56 (-3.32%)
     
  • FTSE

    7,234.03
    +26.32 (+0.37%)
     
  • NIKKEI 225

    29,068.63
    +517.70 (+1.81%)
     
  • CAD/EUR

    0.6966
    -0.0001 (-0.01%)
     
LATEST UPDATE:

NO WEEKLY BRIEF NEWSLETTER FOR THE WEEKEND OF OCT. 16-17

U.S. administers 389.4 million doses of COVID-19 vaccines - CDC

·1 min read
Moderna COVID-19 vaccinations to Sarasota Hospital workers

(Reuters) - The United States has administered 389,372,689 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 471,821,155 doses, the U.S. Centers for Disease Control and Prevention said.

Those totals are up from the 388,567,109 vaccine doses the CDC said had been administered by Sept. 24, out of 470,630,875 doses delivered.

The agency said 213,177,462 people had received at least one dose, while 183,353,326 people were fully vaccinated as of 6:00 a.m. ET on Saturday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech, as well as Johnson & Johnson's one-shot vaccine.

Over 2.5 million people received an additional dose of either Pfizer or Moderna's vaccine since Aug. 13, when U.S. authorities authorized a third dose of the vaccines for people with compromised immune systems who are likely to have weaker protection despite the two-dose regimens.

(Reporting by Bhargav Acharya in Bengaluru; Editing by Dan Grebler)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting